drugset / Trial / NCT00224445
Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
NaSingle-groupOpen-labelTreatment
Summary
To determine the safety and efficacy of a simple, once-daily antiretroviral (ARV) regimen consisting of a fixed-dose combination tablet containing Truvada combined with atazanavir boosted with ritonavir in treatment naive patients.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | 300 mg | Oral |
| Subject | Truvada | Unknown | 200 mg | Oral |
| Subject | Truvada | Unknown | 300 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |